Pentamidine is a broad-spectrum anti-infective agent active against several parasitic worms, protozoa, and fungi. It has been used in the treatment of Pneumocystis jiroveci pneumonia in the immunocompromised, leishmaniasis (cutaneous and visceral), and human African trypanosomiasis (African sleeping sickness). It is a relatively toxic drug and requires careful monitoring during therapy.

FDA Indications:

Pentamidine isethionate is used in the treatment and prevention of  Pneumocystis jirovecii pneumonia in high-risk, HIV-infected patients who meet the following criteria :

- A history of one or more previous episodes of Pneumocystis jiroveci pneumonia

- A CD4+ count of 200 cells/mm^3 or less

Due to its various toxicities, its use is only for severe Pneumocystis jirovecii pneumonia, which has failed to respond to other first-line agents.

Non-FDA approved indications :

Anti Protozoal and Anti Parasitic action: Pentamidine is a treatment for protozoal infections such as cutaneous and visceral leishmaniasis caused by the bite of phlebotomine sand flies.

It is also used to treat a tropical disease like sleeping sickness, known as human African trypanosomiasis, caused by the bite of an infected tsetse fly.Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. It is the drug of choice for stage 1 (hemolymphatic stage) of sleeping sickness caused by Trypanosoma brucei gambiense.